EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Immunotherapy for Hepatocellular Carcinoma in the Setting of Liver Transplantation: A Review

Zurabi Lominadze iD, Kareen Hill, Mohammed Rifat Shaik, Justin P Canakis, Mohammad Bourmaf, Cyrus Adams-Mardi, Ameer Abutaleb, Lopa Mishra, Kirti Shetty

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24032358 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Zurabi Lominadze und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology & Hepatology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Liver Transplantation. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAAA NIH HHS, NCI NIH HHS, NIAAA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emerging field of immuno-oncology has brought exciting developments in the treatment of hepatocellular carcinoma (HCC). It has also raised urgent questions about the role of immunotherapy in the setting of liver transplantation, both before and after transplant. A growing body of evidence points to the safety and efficacy of immunotherapeutic agents as potential adjuncts for successful down-staging of advanced HCCs to allow successful transplant in carefully selected patients. For patients with recurrent HCC post-transplant, immunotherapy has a limited, yet growing role. In this review, we describe optimal regimens in the setting of liver transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsLiver TransplantationHumansImmunotherapy

Stichwörter der Autor:innen

allograft rejectionhepatocellular carcinomaimmunotherapyliver transplantation

Autor:innen und Institutionen

  • Division of Gastroenterology & Hepatology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
  • Department of Medicine, University of Maryland Medical Center, Baltimore, MD 21201, USA.
  • Department of Medicine, University of Maryland Medical Center Midtown Campus, Baltimore, MD 21201, USA.
  • Department of Medicine, George Washington University School of Medicine and Health Sciences, Washington, DC 20037, USA.
  • Department of Surgery, George Washington University School of Medicine and Health Sciences, Washington, DC 20037, USA.
  • Cold Spring Harbor Laboratory, Feinstein Institutes for Medical Research, Division of Gastroenterology and Hepatology, Northwell Health, Manhasset, NY 11030, USA.

ORCID-Profile: Zurabi Lominadze

Förderung

  • NIAAA NIH HHS
  • NCI NIH HHS
  • NIAAA
  • NCI

Zitieren

APA

Lominadze, Z., Hill, K., Shaik, M. R., Canakis, J. P., Bourmaf, M., Adams-Mardi, C., Abutaleb, A., Mishra, L., & Shetty, K. (2023). Immunotherapy for Hepatocellular Carcinoma in the Setting of Liver Transplantation: A Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24032358

Vancouver

Lominadze Z, Hill K, Shaik MR, Canakis JP, Bourmaf M, Adams-Mardi C, et al. Immunotherapy for Hepatocellular Carcinoma in the Setting of Liver Transplantation: A Review. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24032358

BibTeX
@article{Lominadze2023,
  author = {Lominadze, Zurabi and Hill, Kareen and Shaik, Mohammed Rifat and Canakis, Justin P and Bourmaf, Mohammad and Adams-Mardi, Cyrus and Abutaleb, Ameer and Mishra, Lopa and Shetty, Kirti},
  title = {Immunotherapy for Hepatocellular Carcinoma in the Setting of Liver Transplantation: A Review},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24032358}
}
Kostenlos starten →